[Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
D000328:Adult; D001288:Attention / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005464:Fluorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005712:Galvanic Skin Response / Q000187:drug effects; D006801:Humans; D008568:Memory / Q000187:drug effects; D009048:Motor Skills / Q000187:drug effects; D009788:Occupational Therapy; D010465:Perception / Q000187:drug effects; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy* / Q000534:rehabilitation; D013141:Spiro Compounds / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014936:Word Association Tests
D003692:Delayed-Action Preparations; D005464:Fluorobenzenes; D010880:Piperidines; D010919:Placebos; D013141:Spiro Compounds; D014149:Tranquilizing Agents
Erfahrungen mit dem anhaltend wirkenden Neuroleptikum Fluspirilene bei arbeitstherapeutisch beschäftigten chronisch Schizophrenen.